Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 613
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00012350 | Phase II Evaluation of FTase Inhibitor (FTI)in Treatment of Advanced Multiple Myeloma | ||
| NCT03543969 | Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma | ||
| NCT01385956 | SOM 230 and Gemcitabine in Advanced Pancreatic Cancer | ||
| NCT01024387 | AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors | ||
| NCT04191187 | Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies | ||
| NCT00100906 | Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell Cancer | ||
| NCT06553885 | Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC | ||
| NCT00617409 | To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid | ||
| NCT01446952 | Vitamin E δ-Tocotrienol (VEDT) Single Dose in Healthy Subjects | ||
| NCT06002126 | Optimization of Cervical Cancer Screening Among Women Living With HIV in Latin American Countries | ||
| NCT03712943 | Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal Cancer | ||
| NCT03722407 | Ruxolitinib for the Treatment of Chronic Myelomonocytic Leukemia (CMML): A Phase 2 Expansion | ||
| NCT02202499 | Translating Extinction Research to Improve Pharmacotherapy for Tobacco Dependence | ||
| NCT07937423 | DYNAMIC Pilot Optimization Trial | ||
| NCT00006035 | Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma | ||
| NCT00624585 | Study of Oral Dasatinib in Subjects With Myelodysplastic Syndrome (MDS) and Excess Marrow Blasts | ||
| NCT00006376 | R115777 in Treating Patients With Advanced Bladder Cancer | ||
| NCT01400958 | Nuvigil or Placebo in Newly Diagnosed Malignant Glioma | ||
| NCT04923542 | SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases | ||
| NCT07007273 | Pembrolizumab for Advanced Cutaneous Sarcomas Not Including Angiosarcoma | ||
| NCT00042731 | Isoflavones & Lycopene in Localized Prostate Ca:Prior to Radical Prostatectomy | ||
| NCT05379933 | Caregiver Protocol for Remotely Improving, Monitoring, and Extending Quality of Life | ||
| NCT03575325 | Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia | ||
| NCT00005615 | Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa | ||
| NCT03176576 | Patient Navigation in the Adolescent and Young Adult (AYA) Cancer Population | ||
| NCT02721459 | XL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV Melanoma | ||
| NCT03718650 | Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer | ||
| NCT00786760 | Natural History of HPV Infection in Men: The HIM Study | ||
| NCT01754623 | GTX-RT in Borderline Resectable Pancreatic Cancer | ||
| NCT03501368 | Study of Trametinib + Ceritinib in Patients With Unresectable Melanoma | ||
| NCT02631590 | Copanlisib (BAY 80-6946) in Combination With Gemcitabine and Cisplatin in Advanced Cholangiocarcinoma | ||
| NCT07542041 | Artidis Nanomechanical Signature Profiling of Pancreatic Cancer Specimens | ||
| NCT00006031 | Comparison of Two Types of Biopsy in Patients With Breast Lesions | ||
| NCT00226577 | Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer. | ||
| NCT05048316 | Study to Develop a Group-Based E-Health Intervention for YA Cancer Survivors | ||
| NCT03370276 | Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma | ||
| NCT00375024 | Patient Navigator Project | ||
| NCT00803010 | Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell Transplantation | ||
| NCT00005611 | BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment | ||
| NCT01483664 | Communication Skills Intervention to Promote Transition Into Survivorship | ||
| NCT04766164 | Health Beliefs, Behaviors, and Healthcare Experiences Among United States Young and Mid-Age Adults | ||
| NCT01286038 | Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia | ||
| NCT04975152 | Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma | ||
| NCT00948922 | Melphalan+Bortezomib as a Conditioning Regimen for Autologous and Allogeneic Stem Cell Transplants in Multiple Myeloma | ||
| NCT01437605 | Phase II Study to Assess the Safety and Immunogenicity of recMAGE-A3+AS15 ASCI With or Without Poly IC:LC | ||
| NCT04562129 | IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients | ||
| NCT03411031 | Elotuzumab Plus Lenalidomide (Elo/Rev) for Serologic Relapse/Progression While on Lenalidomide | ||
| NCT00720629 | Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation | ||
| NCT02978443 | A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab | ||
| NCT03078348 | Increasing Access to Colorectal Cancer Testing (IACCT) for Blacks |
